skip to content
Detailed Quote
5i Report
Rating
B

Review of Andlauer Healthcare Group Inc.

JUL 16, 2024 - We believe AND will continue to benefit from the long-term secular growth trends in the healthcare transportation market, and growth in its US business can help fuel top and bottom-line growth. For now, it’s a fundamentally-sound company trading at slightly premium valuations, and with somewhat flat year-over-year growth. We believe it has better long-term prospects, and for now, we are maintaining our rating at a ‘B’.

Download Report
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Would 5i comment on earnings for AND and anything you may have gleaned from the report and conference call { if it has happened yet } . I know what the earnings are { down a tad from 2023 but not a lot } but would like to hear 5i's opinions on the business and business model going forward both short and mid to long term .... The stock has been a bit unexciting in the recent past and I am trying to assess whether to move on ...... Thanks for your terrific service . Garth .....
Read Answer Asked by Garth on May 06, 2024
Insiders
Share Information
News and Media